Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03512184 · ClinicalTrials.gov registry record · NA
YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03512184 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 48 participants.
The verdict
NCT03512184, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study is for men and women have been diagnosed with non-alcoholic fatty liver disease (NAFLD) and will consequently participate in the YMCA's Diabetes Prevention Program.
Interventions
- BEHAVIORAL YMCA class
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2021-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03512184
The ClinicalTrials.gov registry entry for NCT03512184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which YMCA class is the first listed.
NCT03512184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03512184 about?
NCT03512184 is a clinical study titled "YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)". This study is for men and women have been diagnosed with non-alcoholic fatty liver disease (NAFLD) and will consequently participate in the YMCA's Diabetes Prevention Program.
What is the current status of trial NCT03512184?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-01-03. Estimated completion is 2021-09-12.
What interventions are being tested in trial NCT03512184?
The interventions under investigation include: YMCA class (BEHAVIORAL).
Who is sponsoring clinical trial NCT03512184?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.